STRATA CRITICAL MEDICAL INC (SRTA) Earnings History & Surprises

NASDAQ:SRTAUS0926671043

Current stock price

4.12 USD
+0.08 (+1.98%)
At close:
4.12 USD
0 (0%)
After Hours:

SRTA Earnings overview

Past quarterly earnings results for STRATA CRITICAL MEDICAL INC (SRTA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
64.949M

Last Reported

Most Recent
Release Date
Mar 3, 2026
Period
Q4 / 2025
EPS Reported
-$0.12
EPS Surprise
-370.59%
Revenue Surprise
8.50%

Beat Rate

Last 8 Quarters
63%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.12 -0.03 -370.59% 7.69% 66.787M 61.557M 8.50% 22.87%
Q3 2025 -0.05 -0.03 -96.08% -66.67% 49.298M 44.88M 9.84% -34.16%
Q2 2025 -0.05 -0.04 -11.41% 66.67% 70.801M 65.36M 8.32% 4.20%
Q1 2025 -0.04 -0.11 64.99% 33.33% 54.306M 50.423M 7.70% 5.42%
Q4 2024 -0.13 -0.10 -24.95% 71.11% 54.357M 52.149M 4.23% 14.49%
Q3 2024 -0.03 -0.05 38.08% - 74.877M 75.934M -1.39% 4.81%
Q2 2024 -0.15 -0.06 -145.10% 11.76% 67.945M 64.379M 5.54% 11.40%
Q1 2024 -0.06 -0.12 50.98% 57.14% 51.514M 50.451M 2.11% 13.79%
Q4 2023 -0.45 -0.13 -246.02% -109.30% 47.478M 49.367M -3.83% 24.48%
Q3 2023 0.00 -0.10 100.00% 100.00% 71.44M 68.281M 4.63% 56.26%
Q2 2023 -0.17 -0.15 -16.96% -270.00% 60.99M 54.927M 11.04% 71.18%
Q1 2023 -0.14 -0.21 34.64% 26.32% 45.27M 41.318M 9.56% 70.00%
Q4 2022 -0.22 -0.17 -26.47% - 38.14M 36.427M 4.70% -
Q3 2022 -0.12 -0.15 19.69% -27.88% 45.72M 39.565M 15.56% 125.00%
Q2 2022 0.10 -0.21 148.00% - 35.63M 28.076M 26.91% 175.14%
Q1 2022 -0.19 -0.20 5.20% - 26.63M 22.094M 20.53% -
Q3 2021 -0.09 - - 20.32M - -
Q2 2021 - - 12.95M - -
Q1 2021 - - - -
Q4 2020 - - - -
Q3 2020 - - - -
Q2 2020 - - - -
Q1 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

SRTA EPS Q2Q GrowthSRTA EPS Q2Q GrowthEPS Q2Q Growth Q3/22 Q2/23 Q4/23 Q2/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 100 -100 -200

Revenue Historical Q2Q growth and Acceleration

SRTA Revenue Q2Q GrowthSRTA Revenue Q2Q GrowthRevenue Q2Q Growth Q2/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 50 100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-103.27%
Max EPS beat (4)
64.99%
Min EPS beat (4)
-370.59%

Revenue beat statistics

Revenue beat (4)
4
Average Revenue beat (4)
8.59%
Max Revenue beat (4)
9.84%
Min Revenue beat (4)
7.70%

Analysis

In the last 4 quarters, SRTA has beaten EPS estimates in 1 out of 4 releases
SRTA has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, SRTA reported -103.3% below the EPS estimates on average.
In the last 4 quarters, SRTA has beaten the revenue estimates by 8.6% on average.

STRATA CRITICAL MEDICAL INC / SRTA Earnings FAQ

When did STRATA CRITICAL MEDICAL INC (SRTA) report earnings last quarter?

STRATA CRITICAL MEDICAL INC (SRTA) last reported earnings on 3/3/2026.

Did STRATA CRITICAL MEDICAL INC (SRTA) beat earnings estimates last quarter?

STRATA CRITICAL MEDICAL INC (SRTA) missed EPS estimates and beat revenue estimates in the most recent quarter.

How often does STRATA CRITICAL MEDICAL INC (SRTA) beat earnings estimates?

In the last 4 quarters, STRATA CRITICAL MEDICAL INC (SRTA) has beaten EPS estimates in 1 out of 4 releases.